More than 30 pharma and biotech companies participated in Alexander Group’s latest 2020 research into market trends and commercial mandates in the pharmaceutical sales industry. Current practices and trends across therapeutic areas such as oncology, rare diseases, diabetes and cardiology provided several key mandates companies should consider to stay ahead of the competition.
Below is an outline of the high-level findings and mandates for change.
For a detailed readout on these commercial mandates for pharma companies along with industry benchmarks and a breakdown of the key leading market models, request a review session.
_______________________
RELATED RESOURCES
1. Executive Interview – Johnson & Johnson MD&D – Lori Tierney
2. Healthcare: Key Areas To Evolve Your Commercial Model
Explore Alexander Group’s library of sales compensation articles, videos, surveys and more!